Literature DB >> 16456039

The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries.

John Stover1, Stefano Bertozzi, Juan-Pablo Gutierrez, Neff Walker, Karen A Stanecki, Robert Greener, Eleanor Gouws, Catherine Hankins, Geoff P Garnett, Joshua A Salomon, J Ties Boerma, Paul De Lay, Peter D Ghys.   

Abstract

A strong, global commitment to expanded prevention programs targeted at sexual transmission and transmission among injecting drug users, started now, could avert 28 million new HIV infections between 2005 and 2015. This figure is more than half of the new infections that might otherwise occur during that period in 125 low- and middle-income countries. Although preventing these new infections would require investing about U.S.$122 billion over this period, it would reduce future needs for treatment and care. Our analysis suggests that it will cost about U.S.$3900 to prevent each new infection, but that this will produce a savings of U.S.$4700 in forgone treatment and care costs. Thus, greater spending on prevention now would not only prevent more than half the new infections that would occur from 2005 to 2015 but would actually produce a net financial saving as future costs for treatment and care are averted.

Entities:  

Mesh:

Year:  2006        PMID: 16456039     DOI: 10.1126/science.1121176

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  44 in total

1.  A comparison of HIV detection rates using routine opt-out provider-initiated HIV testing and counseling versus a standard of care approach in a rural African setting.

Authors:  David M Silvestri; Kayvon Modjarrad; Meridith L Blevins; Elizabeth Halale; Sten H Vermund; Jeffry P McKinzie
Journal:  J Acquir Immune Defic Syndr       Date:  2011-01-01       Impact factor: 3.731

2.  Improving analysis of the size and dynamics of AIDS epidemics.

Authors:  P D Ghys; N Walker; G P Garnett
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

3.  Changing cost of HIV interventions in the context of scaling-up in India.

Authors:  Lalit Dandona; Sg Prem Kumar; Yk Ramesh; M Chalapathi Rao; A Anod Kumar; Elliot Marseille; James G Kahn; Rakhi Dandona
Journal:  AIDS       Date:  2008-07       Impact factor: 4.177

4.  The welfare costs of HIV/AIDS in eastern Europe: an empirical assessment using the economic value-of-life approach.

Authors:  Julia Fimpel; Michael Stolpe
Journal:  Eur J Health Econ       Date:  2009-08-05

Review 5.  The spread, treatment, and prevention of HIV-1: evolution of a global pandemic.

Authors:  Myron S Cohen; Nick Hellmann; Jay A Levy; Kevin DeCock; Joep Lange
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

6.  Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.

Authors:  Elisa F Long; Robert R Stavert
Journal:  J Gen Intern Med       Date:  2013-04-16       Impact factor: 5.128

7.  Inexpensive designer antigen for anti-HIV antibody detection with high sensitivity and specificity.

Authors:  Sheikh M Talha; Teppo Salminen; Deepti A Chugh; Sathyamangalam Swaminathan; Tero Soukka; Kim Pettersson; Navin Khanna
Journal:  Clin Vaccine Immunol       Date:  2010-01-20

8.  Determining a cost effective intervention response to HIV/AIDS in Peru.

Authors:  Robert W Aldridge; David Iglesias; Carlos F Cáceres; J Jaime Miranda
Journal:  BMC Public Health       Date:  2009-09-18       Impact factor: 3.295

9.  Can we spend our way out of the AIDS epidemic? A world halting AIDS model.

Authors:  Robert J Smith; Jing Li; Richard Gordon; Jane M Heffernan
Journal:  BMC Public Health       Date:  2009-11-18       Impact factor: 3.295

Review 10.  HIV prevention cost-effectiveness: a systematic review.

Authors:  Omar Galárraga; M Arantxa Colchero; Richard G Wamai; Stefano M Bertozzi
Journal:  BMC Public Health       Date:  2009-11-18       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.